Investigation of the Effect of Macitentan on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects

被引：0
|
作者：
Patricia N. Sidharta
Hartmut Dietrich
Jasper Dingemanse
机构：
[1] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] ClinPharmCologne,undefined
[3] MEDA Manufacturing GmbH,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Warfarin; Pulmonary Arterial Hypertension; International Normalise Ratio; Dabigatran; Rivaroxaban;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 552
页数：7
相关论文
共 50 条
  • [21] Effect of Eslicarbazepine Acetate on the Steady-State Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
    Zummo, Jacqueline
    Vaz-da-Silva, Manuel
    Almeida, Luis
    Falcao, Amilcar
    Versavel, Mark
    Soares, Eva
    Maia, Joana
    Nunes, Teresa
    NEUROLOGY, 2010, 74 (09) : A458 - A458
  • [22] The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
    Zhi, JG
    Melia, AT
    Guerciolini, R
    KossTwardy, SG
    Passe, SM
    Rakhit, A
    Sadowski, JA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (07): : 659 - 666
  • [23] Effect of linagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
    Graefe-Mody, E. U.
    Brand, T.
    Ring, A.
    Withopf, B.
    Stangier, J.
    Iovino, M.
    Woerle, H. -J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (05) : 300 - 310
  • [24] Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
    Van Hecken, A
    Depré, M
    Verbesselt, R
    Wynants, K
    De Lepeleire, I
    Arnout, J
    Wong, PH
    Freeman, A
    Holland, S
    Gertz, B
    De Schepper, PJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (05): : 495 - 500
  • [25] Effect of Carisbamate on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Participants
    Gonzalez, Martha
    Zannikos, Peter
    DiBernardo, Allitia
    Brashear, H. Robert
    Ariyawansa, Jay
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (09): : 1420 - 1429
  • [26] Thalomid® (thalidomide) does not affect the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Wu, A
    Patin, J
    Shenouda, M
    Ayalasomayajula, S
    DeGroot, B
    Scheffler, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1076 - 1076
  • [27] Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects
    Chappell, Jill
    He, Jingsong
    Knadler, Mary Pat
    Mitchell, Malcolm
    Lee, Douglas
    Lobo, Evelyn
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (12): : 1456 - 1466
  • [28] Effect of vildagliptin on the pharmacokinetic and pharmacodynamics of warfarin in healthy subjects
    He, Y. L.
    Sabo, R.
    Leon, S.
    Riviere, G.
    Sunkara, G.
    Ligueros-Saylan, M.
    Dole, W. P.
    Howard, D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1082 - 1082
  • [29] Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects
    Dieterle, W
    Corynen, S
    Mann, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) : 433 - 436
  • [30] Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
    Csonka, Denes
    Bruderer, Shirin
    Schultz, Armin
    Soergel, Marianne
    Stepanova, Radka
    Sabattini, Giancarlo
    Perez-Ruixo, Juan Jose
    CLINICAL DRUG INVESTIGATION, 2019, 39 (12) : 1223 - 1232
12345